A 51-year-old Iranian Woman with Chronic HBV Infection with Reversible Cirrhosis after Tenofovir Therapy
Little data exist on patients treated with tenofovir and reversible cirrhosis in Iran. A 51-year-old Iranian woman with chronic HBV infection and positive serum hepatitis B surface antigen (HBsAg) presented with abnormal liver function tests. Because of severe fibrosis that was reported in liver bio...
Main Authors: | Mahboubeh HAJIABDOLBAGHI, Elham RAISI, Jaleh BAYANI, Fereshteh GHIASVAND |
---|---|
Format: | Article |
Language: | English |
Published: |
Third Party Medicine International Publishing Group Co. Limited
2018-12-01
|
Series: | Journal of International Translational Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.11910/2227-6394.2018.06.04.06 |
Similar Items
-
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
by: Ping Zhang, et al.
Published: (2018-08-01) -
Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
by: Mireia Miquel, et al.
Published: (2013-03-01) -
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Chen, L., et al.
Published: (2022) -
Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021-08-01) -
Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017-09-01)